Hybrid eventIn-person & virtual
March 15–17, 2027Singapore · Village Hotel Changi
Session Track · CIOC 2027

Ovarian Germ Cell Tumors at CIOC 2027

Part of the CIOC 2027 scientific programme · Village Hotel Changi, Singapore · March 15–17, 2027

About the Ovarian Germ Cell Tumors Session

Ovarian germ cell tumors (OGCTs) are a rare subset of ovarian cancers, originating from the primitive germ cells of the embryonic gonad. They primarily affect adolescents and young women, often presenting with abdominal pain and masses. Research advancements have significantly improved the prognosis for OGCTs, with multimodal treatments combining surgery and chemotherapy proving highly effective. Chemotherapeutic regimens, particularly those including platinum-based compounds, have shown high cure rates even in advanced stages. Ongoing studies focus on minimizing treatment-related toxicity and exploring the molecular genetics of OGCTs to develop targeted therapies. Innovations in fertility preservation are also enhancing quality of life for survivors, addressing a critical concern for this young patient demographic.

Topics Covered in Ovarian Germ Cell Tumors

Topic 01

Dysgerminoma

Topic 02

Yolk Sac Tumor

Topic 03

Serum Tumor Markers

Topic 04

Fertility-Sparing Surgery

Topic 05

Platinum-Based Chemotherapy

Topic 06

Long-Term Survivorship

Related Scientific Sessions at CIOC 2027

Why Attend the Ovarian Germ Cell Tumors Conference 2027

Earn CPD Credit

Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.

Present Your Research

Oral and poster slots for original Ovarian Germ Cell Tumors work, reviewed by the scientific committee.

Network Globally

Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.

Publish & Get Indexed

Accepted abstracts appear in the indexed conference proceedings with a citable DOI.

Learn from Keynotes

Plenary lectures from leading voices shaping Ovarian Germ Cell Tumors research and practice.

Hybrid Flexibility

Attend in person in Singapore or join virtually — same programme, same certificate.

Join CIOC 2027 for the Ovarian Germ Cell Tumors track

Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.

Ovarian Germ Cell Tumors Conference 2027 — FAQs

What is the Ovarian Germ Cell Tumors track at CIOC 2027?

The Ovarian Germ Cell Tumors track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Ovarian Germ Cell Tumors. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Ovarian Germ Cell Tumors sessions?

Cancer researchers and clinicians, educators and students with an interest in Ovarian Germ Cell Tumors are all welcome — whether presenting or attending.

Can I present my research in the Ovarian Germ Cell Tumors track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Ovarian Germ Cell Tumors sessions?

Yes. CIOC 2027 is a hybrid conference — attend the Ovarian Germ Cell Tumors track in person in Singapore or join live online, with on-demand access afterward.

Join the CIOC 2027 delegation

Singapore · March 15–17, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us